Insmed To Present at November 2024 Investor Conferences
Insmed (Nasdaq: INSM) has announced its participation in four major healthcare investor conferences in November 2024. The company will present at the Guggenheim Healthcare Innovation Conference in Boston (Nov. 11), UBS Global Healthcare Conference in Rancho Palos Verdes (Nov. 12), Wolfe Research Healthcare Conference in New York (Nov. 20), and Jefferies London Healthcare Conference in London (Nov. 21). All presentations will be webcast live through Insmed's investor relations website and archived for 30 days after the events.
Insmed (Nasdaq: INSM) ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nel settore sanitario nel novembre 2024. L'azienda presenterà alla Guggenheim Healthcare Innovation Conference a Boston (11 novembre), alla UBS Global Healthcare Conference a Rancho Palos Verdes (12 novembre), alla Wolfe Research Healthcare Conference a New York (20 novembre) e alla Jefferies London Healthcare Conference a Londra (21 novembre). Tutte le presentazioni saranno trasmesse in diretta tramite il sito web delle relazioni con gli investitori di Insmed e saranno archiviate per 30 giorni dopo gli eventi.
Insmed (Nasdaq: INSM) ha anunciado su participación en cuatro importantes conferencias de inversores en el sector de la salud en noviembre de 2024. La empresa presentará en la Guggenheim Healthcare Innovation Conference en Boston (11 de noviembre), en la UBS Global Healthcare Conference en Rancho Palos Verdes (12 de noviembre), en la Wolfe Research Healthcare Conference en Nueva York (20 de noviembre) y en la Jefferies London Healthcare Conference en Londres (21 de noviembre). Todas las presentaciones se transmitirán en vivo a través del sitio web de relaciones con inversores de Insmed y se archivaràn durante 30 días después de los eventos.
인스메드 (Nasdaq: INSM)는 2024년 11월에 열리는 네 개의 주요 헬스케어 투자자 회의에 참여한다고 발표했습니다. 회사는 보스턴에서 열리는 구겐하임 헬스케어 혁신 컨퍼런스 (11월 11일), 랜초 팔로스 베르데스에서 열리는 UBS 글로벌 헬스케어 컨퍼런스 (11월 12일), 뉴욕에서 열리는 울프 리서치 헬스케어 컨퍼런스 (11월 20일), 그리고 런던에서 열리는 제프리스 런던 헬스케어 컨퍼런스 (11월 21일)에서 발표할 예정입니다. 모든 발표는 인스메드의 투자자 관계 웹사이트를 통해 실시간으로 방송되며, 행사 후 30일 동안 보관됩니다.
Insmed (Nasdaq: INSM) a annoncé sa participation à quatre grandes conférences pour investisseurs dans le secteur de la santé en novembre 2024. L'entreprise présentera à la Guggenheim Healthcare Innovation Conference à Boston (11 novembre), à la UBS Global Healthcare Conference à Rancho Palos Verdes (12 novembre), à la Wolfe Research Healthcare Conference à New York (20 novembre) et à la Jefferies London Healthcare Conference à Londres (21 novembre). Toutes les présentations seront diffusées en direct via le site web des relations investisseurs d'Insmed et archivées pendant 30 jours après les événements.
Insmed (Nasdaq: INSM) hat seine Teilnahme an vier wichtigen Investorenkonferenzen im Gesundheitswesen im November 2024 angekündigt. Das Unternehmen wird auf der Guggenheim Healthcare Innovation Conference in Boston (11. November), der UBS Global Healthcare Conference in Rancho Palos Verdes (12. November), der Wolfe Research Healthcare Conference in New York (20. November) und der Jefferies London Healthcare Conference in London (21. November) präsentieren. Alle Präsentationen werden live über die Investor Relations-Website von Insmed übertragen und 30 Tage nach den Veranstaltungen archiviert.
- None.
- None.
- Guggenheim's Inaugural Healthcare Innovation Conference in
Boston on Monday, November 11, 2024, at 1:00 p.m. ET. - UBS Global Healthcare Conference in Rancho Palos Verdes, Calif., on Tuesday, November 12, 2024, at 11:45 a.m. PT / 2:45 p.m. ET.
- Wolfe Research Healthcare Conference in
New York on Wednesday, November 20, 2024, at 8:00 a.m. ET. - Jefferies London Healthcare Conference in
London on Thursday, November 21, 2024, at 8:30 a.m. GT / 3:30 a.m. ET.
These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in
Headquartered in
Contact:
Investors:
Bryan Dunn
Executive Director, Investor Relations
(646) 812-4030
bryan.dunn@insmed.com
Michael V. Morabito, Ph.D.
Director, Investor Relations
(917) 936-8430
michael.morabito@insmed.com
Gianna De Palma
Manager, Investor Relations
(973) 886-2236
gianna.depalma@insmed.com
Media:
Mandy Fahey
Vice President, Corporate Communications
(732) 718-3621
amanda.fahey@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-november-2024-investor-conferences-302296893.html
SOURCE Insmed Incorporated
FAQ
What investor conferences will Insmed (INSM) attend in November 2024?
How can investors access Insmed's (INSM) November 2024 conference presentations?
What time is Insmed's (INSM) presentation at the UBS Global Healthcare Conference on November 12, 2024?